This Key Piece Of News Could Sparked BioNTech, Moderna — And Could Stoke Demand For Covid BoostersInvestors Business Daily • 11/04/22
Is Moderna Stock A Buy Or A Sell As It Yo-Yos On An Influx Of Covid News?Investors Business Daily • 11/04/22
Global tally of COVID cases and deaths continues to fall; Moderna cuts vaccine-sales outlook by up to $3 billionMarket Watch • 11/03/22
Moderna tanks 14% after COVID-19 vaccine maker cuts yearly sales outlook and misses 3rd-quarter expectationsBusiness Insider • 11/03/22
Moderna Plummets After Slashing 2022 Outlook Following Massive Quarterly MissInvestors Business Daily • 11/03/22
Moderna stock slides 11.5% premarket after earnings miss by a wide margin and company cuts sales outlook by up to $3 billionMarket Watch • 11/03/22
Moderna Reports Third Quarter 2022 Financial Results and Provides Business UpdatesAccesswire • 11/03/22
Ministry of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna's Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.222Accesswire • 11/01/22
Moderna to Host First Environmental, Social and Governance (ESG) Day on November 10, 2022Accesswire • 10/27/22
Which Stocks Are Most Likely to Thrive in a Recession? Here's What History ShowsThe Motley Fool • 10/23/22